Affordable Access

deepdyve-link
Publisher Website

Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial.

Authors
  • Rousseau, Annick1
  • Laroche, Marie-Laure
  • Venisse, Nicolas
  • Loichot-Roselmac, Cecile
  • Turcant, Alain
  • Hoizey, Guillaume
  • Compagnon, Patricia
  • Hary, Lionel
  • Debruyne, Danièle
  • Saivin, Sylvie
  • Jacqz-Aigrain, Evelyne
  • Buchler, Mathias
  • Villeneuve, Claire
  • Vergnenègre, Alain
  • Le Meur, Yannick
  • Marquet, Pierre
  • 1 INSERM UMR-S850, Limoges, France. , (France)
Type
Published Article
Journal
Transplantation
Publication Date
May 27, 2010
Volume
89
Issue
10
Pages
1255–1262
Identifiers
DOI: 10.1097/TP.0b013e3181d75952
PMID: 20224514
Source
Medline
License
Unknown

Abstract

In the APOMYGRE trial, therapeutic MPA monitoring using a limited sampling strategy reduced the risk of treatment failure and acute rejection in renal allograft recipients during the first 12 months posttransplantation, at neutral cost.

Report this publication

Statistics

Seen <100 times